Medicon Valley Alliance and Clario would like to welcome you to a Good Morning Meeting 7th of May 2025.
Discover an informative seminar delving into the transformative role of artificial intelligence (AI) in clinical trials: where the industry is currently at, common misconceptions in leveraging AI, proactively tackling the potential for bias and navigating the current regulatory landscape.
In its current state, AI can help optimize operations, integrate platforms, strengthen patient privacy and improve data quality while reducing the risk of human error in clinical trials. AI must be used responsibly and be governed by the highest ethical principles when used in clinical trials. This includes data privacy considerations, and efforts to reduce bias in algorithm performance. Following current regulatory guidance and a company code of conduct, AI, machine learning and deep learning capabilities are responsible across more than 600 ongoing, active clinical trials.
Join this event to gain an understanding of the responsible application of AI-enabled algorithms in clinical trial endpoint collection and data analysis
Date: Wednesday 7th of May 2025
Time: 9:00 – 11:30
Venue: Medicon Valley Alliance, Arne Jacobsens Allé 15, 2300 Copenhagen S, Denmark – Hub 2
Program
| 9:00 | Networking, registration and light breakfast |
| 9:30 | Welcome and introduction to Medicon Valley Alliance David Munis Zepernick, Director, Member Engagement & Communication, Medicon Valley Alliance |
| 9:35 | Clario Digital Endpoint Platform As an industry leader in clinical endpoint technology, Clario are continually looking for ways to better service the market and navigate the changing complexity of the regulatory landscape Oliver Drayton, Executive Director, Cardiac Solutions |
| 9:40 | Responsibly Advancing the Use of AI in Clinical Trials • AI for clinical research: basic concepts • Regulations as a source of inspiration • Common misconceptions • Current AI implementations & their proofpoints • How to recognize & validate AI opportunities for your organization Benoit Cuyvers, AI Innovation Lead- Digital Physiology, Clario |
| 10:25 | Conclusions: A quick recap of the key learning points |
| 10:40 | Q&A session |
| 11:00 | Networking |
| 11:30 | End of Good Morning Meeting |
Speakers
 |
Benoit Cuyvers, AI Innovation Lead- Digital Physiology at Clario
Benoit Cuyvers is the Upstream AI (Artificial Intelligence) Product Manager for Clario, recently joining the team from the ArtiQ acquisition. The acquisition advances our respiratory solutions portfolio, combining Clario’s deep scientific expertise with ArtiQ’s innovative artificial intelligence capabilities. In his new role at Clario, Benoit is responsible for the innovation management for AI solutions in respiratory & cardiology. With his background in Bioscience Engineering and his past experience as a digital health expert at Siemens, Benoit is able to apply learnings from other medical and technical fields to the field of AI in respiratory research & medicine. |
 |
Oliver Drayton, Executive Director, Cardiac Solutions at Clario
As the Executive Director of Cardiac Solutions, EMEA & APAC at Clario, Oliver leads a team of cardiac specialists who deliver best-in-class solutions for decentralized, hybrid, and site-based clinical trials, helping to drive regulatory in clinical decisions around safety and efficacy. |
| Organized by | In collaboration with |
 |
 |